OBX

Obsidian Therapeutics, Inc.

Healthcare · Biotechnology

14.60$ +9.1% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement OBX
Line item	2024	2025
Revenue	–	–
Research & Development	–	+17.7%
Selling, General & Administrative	–	+8.2%
Total Operating Expenses	–	+15.8%
Operating Income	–	–
Pre-Tax Income	–	–
Net Income	–	–

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.